Previous 10 | Next 10 |
home / stock / mkgaf / mkgaf news
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2020 Q4 earnings call. For further details see: MERCK Kommanditgesellschaft auf Aktien 2020 Q4 - Results - Earnings Call Presentation
MERCK Kommanditgesellschaft auf Aktien (MKGAF): FY Non-GAAP EPS of €6.70; GAAP EPS of €4.57.Revenue of €17.53B (+8.5% Y/Y)Press Release For further details see: MERCK Kommanditgesellschaft auf Aktien reports FY results
Merck KGaA (MKGAF) announces a worldwide in-licensing agreement with Debiopharm, Switzerland, for the development and commercialization of xevinapant (Debio 1143).Under the terms of agreement, Merck KGaA, gains exclusive rights to develop and commercialize xevinapant worldwide, incl...
Merck KgaA (MKGAF) says that it will ‘significantly accelerate’ the supply of lipids and speed up the lipid delivery towards the end of 2021 for the production of COVID-19 vaccine developed by Pfizer (PFE) and BioNTech (BNTX).Speaking to Bloomberg TV, CEO of CureVac, Franz...
F-star Therapeutics (FSTX) jumps 16% premarket after Merck KGaA (MKGAF) reports 5.4% passive stake in the company.Press Release For further details see: Merck KGaA discloses 5.4% stake in F-star Therapeutics
EMD Serono, the Healthcare business sector of (PFE) and Merck KGaA (MKGAF) announce that the European Commission ((EC)) has approved Bavencio (avelumab) as monotherapy for the first-line maintenance treatment of adult patients with urothelial carcinoma ((UC)) who are progression-free fol...
Merck KGaA (MKGAF) and GlaxoSmithKline (GSK) have ended the INTR@PID Lung 037 Phase 3 trial of cancer drug bintrafusp alpha, based on lack of efficacy.The study was looking at bintrafusp alpha to treat non small-cell lung cancer in comparison to Merck's (MRK) KeytrudaMerck KGaA is develo...
Merck KGaA, Darmstadt, Germany, to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 19 November 2020 Merck KGaA invites individual and institutional investors, as well as advisors, to attend interactive, real-time virtual event PR Newswire DARMSTAD...
MERCK Kommanditgesellschaft auf Aktien (MKGAF) Q3 2020 Earnings Conference Call November 12, 2020 8:00 AM ET Company Participants Constantin Fest – Head-Investor Relations Marcus Kuhnert – Chief Financial Officer Chris Ross – Interim Sector Head-Life Science Darren Verlen...
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2020 Q3 earnings call. For further details see: MERCK Kommanditgesellschaft auf Aktien 2020 Q3 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Merck Kgaa Company Name:
MKGAF Stock Symbol:
OTCMKTS Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...